Pathophysiological Aspects of Proteases in Cancer

Herausgeber: Chakraborti, Sajal; Kim, Cheorl-Ho; Das, Srijit

• Broschiertes Buch

Produktbeschreibung

Pathophysiological Aspects of Proteases in Cancer provides a comprehensive overview of the multifaceted field of proteases in the cellular environment and focuses on the recently elucidated functions of complex proteolytic systems in physiology and pathophysiology. The book both gives insights on the general aspects of the role of proteases in cancer, their role as diagnostics and prognostics biomarkers, their impact on chemoresistance, and the future cutting-edge technologies like cocktail therapies and Cyber Knife technology. Given the breadth and depth of information covered in the respective contributions, the book will be immensely useful for researchers in oncology and working to identify targets for drug development. Multidisciplinary in scope, the book bridges the gap between fundamental and translational research, with applications in the biomedical and pharmaceutical industry, making it a thought-provoking read for basic and applied scientists engaged in biomedical research.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science
• Seitenzahl: 648
• Erscheinungstermin: 25. Oktober 2024
• Englisch
• Gewicht: 450g
• ISBN-13: 9780443300981
• ISBN-10: 0443300984
• Artikelnr.: 70704920

Inhaltsangabe

Section I: General Aspects
1. Pathophysiological aspects of calpains in cancer
2. Mitochondrial proteases in cancer development and progression
3. Proteases in Head and Neck Cancer
4. Matrix metalloproteases and uveal melanomas
5. Proteases in DNA damage, repair and radio resistance: Cellular and
Molecular aspects
6. Radiotherapy, proteases and gastric cancer: a complex interplay
7. Matrix metalloproteases in the pathogenesis of hepatocarcinoma
8. Exploring synthetic and natural compounds for Cathepsin B: Mechanisms
and therapy
9. Kallikrein-related peptidase 3 (KLK3) as valuable biomarkers for
prostate cancer
10. Ubiquitin -specific protease 3,7 in bone cancer and squamous cell
carcinoma
11. Serine protease: structure, classification, mechanism and role in
breast cancer
Section II: Proteases as Diagnostics and Prognostics Biomarkers
12. Protease activator receptor-1 and matrix metalloproteinase-1 as
prognostic factors and novel therapeutic targets for gastric cancer
13. Matrix metalloproteases as diagnostic and prognostic biomarkers in
cancer
14. From enzyme to predictors: Serine proteases in cancer diagnosis and
prognosis
15. Cathepsins as a diagnostic and prognostic marker in Oral cancer
16. Role of Kallikreins in Prostate Cancer
17. Mechanistic aspects of Serine Protease as biomarkers in wound healing
of lung cancer
18. The role of acetylcholinesterase in cancer development and possible
therapeutic applications
19. Therapeutics of animal derived compounds in proteases induced cancer
20. Molecular Warriors: Proteases as Sentinels in the War Against Cancer
Diagnosis and Prognosis
Section III: Proteases, Chemoresistance and Cancer
21. Serine proteases, chemoresistance and cancer
22. Cathepsins, chemoresistance and cancer
23. ix metalloproteases, chemoresistance and cancer
24. MMPs (-2 and -9) mediated drug resistance and their reversal in
gynecological cancer
25. The link between trypsinogen and chymotrypsinogen in gastrointestinal
cancer
26. Role of the proteasome in the development of chemoresistance in
multiple myeloma
27. Role of cysteine cathepsin and matrix metalloproteases in progression
and chemoresistance in ovarian and breast cancer
28. Proteases, chemoresistance and cancer
29. Breaking Barriers: Proteases as Key Players in Cancer Chemoresistance
Section IV: Other Aspects
30. Matrix metalloproteases-targeting low molecular weight compound
31. Synthetic protease inhibitors in oral, head and neck cancer: evidence
from clinical trials.
32. Synthetic protease inhibitors in endocrine and gastroenterology
cancers: results of clinical trials
33. Side effects of synthetic protease inhibitors used in gynecology
cancers
34. Role of synthetic compounds with protease inhibitory activity in breast
cancer
35. Cathepsin responsive nanomaterials for targeted delivery of malignant
tumors